Acute lymphoblastic leukaemia: prognostic factors
What it is
Acute lymphoblastic leukemia is a malignant disease of the bone marrow in which early lymphoid precursors proliferate and replace the normal hematopoietic cells of the marrow. It is more common in the pediatric age group. WHO subdivides it into two types by cell of origin: B lymphoblastic leukemia, 80%-85% of the cases, and T lymphoblastic leukemia, 15%-20%. The more common one is also the better one.
The WHO 2016 classification names B-lymphoblastic leukemia or lymphoma, NOS, then a set with recurrent genetic abnormalities: t(9;22)(q34.1;q11.2) BCR-ABL1; t(v;11q23.3) with KMT2A rearranged; t(12;21)(p13.2;q22.1) ETV6-RUNX1; hyperdiploidy; hypodiploidy; t(5;14)(q31.1;q32.3) IL3-IGH; and t(1;19)(q23;p13.3) TCF3-PBX1.
How it presents
Fatigue and bruises bring the child in, and the CBC shows the marrow has been taken over: a hemoglobin of 7.8 g/dl, a WBC of 26x10^9/L and a platelet count of 14x10^9/L.
How it is diagnosed
The peripheral blood film shows circulating blast cells, and the bone marrow biopsy shows the blast percentage, which can reach 92%. The immunophenotype on that marrow is what names the disease, such as T cell lymphoblastic leukemia (T-ALL), and the cytogenetic analysis on the aspirate adds the genotype, such as hyperdiploidy.
Causes and risk
Risk stratification uses the same five factors in adults and in the pediatric group, but the numbers differ.
In adults, favorable against adverse:
- Age: under 35 against over 60
- Leukocyte count: under 30 for B-cell against over 100 for T-cell
- Immunophenotype: thymic T-ALL against early T-cell precursor, in some studies
- Genotype: high hyperdiploid, in some studies, against BCR-ABL1, MLL-rearrangement and hypodiploidy under 44
- Minimal residual disease after induction: low or absent against high
In the pediatric group, favorable against adverse:
- Age: 1 to 9 against under 1 or over 10
- Leukocyte count: under 50 against over 50
- Immunophenotype: B-lymphoblastic against T-cell
- Genotype: hyperdiploidy over 50 and ETV6-RUNX1 against hypodiploidy under 44, MLL-AF4, and IKZF1 deletions or mutations
- Minimal residual disease after induction: under 0.01% against over 1%
So in a boy of 5 with a WBC of 26x10^9/L, the age and the count are both on the favorable side; the poor factor is the type of leukemia, because T cell disease is the adverse immunophenotype. Taken the other way, in a girl of 10 recently diagnosed with T cell acute lymphoblastic leukemia, with a total white count at diagnosis of 30x10^9/L and hyperdiploidy on cytogenetic analysis of the bone marrow aspirate, the most favorable prognostic marker is the cytogenetic finding and not the age, the white count, the female gender or the disease phenotype.
The same factors are set down a second time as a short list of good prognostic factors, with the survival numbers beside them: between 1 year and 10 years of age, WBC below 50 x 109/L, B-cell phenotype, achieving CR after the first induction, and negative MRD after induction; no testicular involvement is also considered a good prognostic factor. Achievement of first remission is 60-90%. Childhood ALL has a 75% 5-year survival, and adult ALL a 30-40% 5-year survival. So survival in this disease is given at 5 years, and the childhood number is roughly twice the adult one.